A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
Clinical trial NCT05906992 · RECRUITING
Trial details
- NCT number
- NCT05906992
- Sponsor
- Celltrion
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-11
- Primary completion
- 2027-02-01
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.